Rigel Pharmaceuticals (RIGL) EBITDA Margin (2010 - 2026)
Rigel Pharmaceuticals (RIGL) reported EBITDA Margin of 31.03% for Q2 2026, down 29.66 percentage points from 60.69% a year earlier but up 9.81 percentage points from the prior quarter.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) EBITDA Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Rigel Pharmaceuticals' EBITDA Margin came in at 32.41%, down 7.53 percentage points year-over-year; for FY2025, it came in at 43.46%, up 28.72 percentage points from FY2024.
- EBITDA Margin has increased for three consecutive years, with a five-year change of +69.48 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at 14.74% in FY2024 (+31.21 pp), -16.47% in FY2023 (+28.90 pp), -45.37% in FY2022 (-37.77 pp) and -7.59% in FY2021 (+18.43 pp).
- Five-year quarterly EBITDA Margin spans a low of -155.51% in Q1 2022 and a high of 60.69% in Q2 2025.
- Year over year, EBITDA Margin gained in six of the last eight quarters, with an average year-over-year change of +19.50 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q1 2023 (a gain of 108.06 percentage points); the low point was Q1 2022 (a drop of 207.34 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 21.22% (Q1 2026), 34.05% (Q4 2025) and 41.78% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Rigel Pharmaceuticals | 922.04 Mn | 387.93 Mn | 70.18 Mn | 31.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.03% |
| Mar 31, 2026 | 21.22% |
| Dec 31, 2025 | 34.05% |
| Sep 30, 2025 | 41.78% |
| Jun 30, 2025 | 60.69% |
| Mar 31, 2025 | 25.08% |
| Dec 31, 2024 | 29.97% |
| Sep 30, 2024 | 26.52% |
| Jun 30, 2024 | 2.88% |
| Mar 31, 2024 | -22.23% |
| Dec 31, 2023 | 6.31% |
| Sep 30, 2023 | -14.83% |
| Jun 30, 2023 | -18.49% |
| Mar 31, 2023 | -47.44% |
| Dec 31, 2022 | 4.61% |
| Sep 30, 2022 | -81.05% |
| Jun 30, 2022 | -42.68% |
| Mar 31, 2022 | -155.51% |
| Dec 31, 2021 | -102.96% |
| Sep 30, 2021 | -90.63% |
API Access
Rigel Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RIGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RIGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RIGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();